AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Tissue Dielectric Constant Measurement
Description: Sub-tissue fluid proportion will be evaluated via Moisture Meter D (Delfin Technologies, Kuopio, Finland) on both upper extremity (right and left) in predefined reference points on volar side (6 cm distal and 8 cm proximal points from cubital crease, 10 cm inferior side point from axilla and dorsal point of web space in the hand) by using four different probes which can assess 0.5 mm, 1.5 mm, 2.5 mm and 5.0 mm depth. Values taken by 2.5 mm depth probe will be used to calculate the ratio (affected side TDC value/Unaffected side TDC value) to stage lymphedema severity along with the International Society of Lymphology staging system. This device mainly aims to assess the dielectric constant of tissues which is related to the amount of tissue water. In the case of pre-lymphedema or lymphedema, one can assess objectively regarding sub-tissue fluid changes via this device. Triplicate measurements will be taken for each reference point.
Study NCT04245657 — intervention group
Intervention type: OTHER
Intervention: Muscle strength measurement
Description: Participants' muscle strength of shoulder flexion, abduction, and elbow flexion will be assessed via Handheld digital dynamometer (Lafayette Manual Muscle Tester, Model 01165, LaFayette Instruments, NY, USA). Both upper extremities will be assessed three times and the average value will be recorded.
Study NCT02970422 — intervention group
Intervention type: OTHER
Intervention: Patient Survey
Description: Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Study NCT03902015 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nuance Phone case
Description: participants will receive a phone (iPhone) with the Nuance Phone case and a designated app required for the use of the device. Participants will first undergo hearing test via the app, and afterwards (in case they are not excluded based on hearing status), will receive a introduction on how to use the app and the device. Before starting the clinical trial, children will undergo three adjustments days in which they will practice using the device in school. During this period the researchers will make sure that the participants are adapting to the use of the device, and in any case there is a problem, will be able to contact a representative of Nuance Hearing who will be available to support technical issues.
Study NCT04213469 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
Description: Gene editing autologous T cells with anti-CD19 ScFv expression and knockout of PD1
Study NCT02522429 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Intensity Focused Ultrasound Device
Description: Low Intensity Focused Ultrasound Pulsation (LIFUP) of thalamus (a key area for the consciousness network) will be performed during two sessions (one occurring after deep sedation is stopped and the second one occurring just before discharge). The proposed experiment will involve behavioral (i.e., CRS-R) and paramedical (i.e., MRI/fMRI and EEG) measurements just before and after each of the two LIFUP sessions (i.e., 5 non-consecutive minutes of stimulation in each session).
Study NCT00294671 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: diflunisal
Description: given twice daily for 24 months
Study NCT00294671 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: an inactive substance given twice daily for 24 months
Study NCT02259725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: regorafenib
Description: Given PO
Study NCT02259725 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT03689049 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SPIDER
Description: The SPIDER intervention will include a family physician-led inter-professional practice team participating in 3-4 Learning Collaboratives over a period of 12 months, reviewing validated and comparable practice EMR data and working with a QI Coach to develop strategies and implement changes to improve care for elderly patients living with complex care needs and taking ten or more unique medications.
Study NCT03689049 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Physicians and their teams enrolled in this arm will follow the best scientific evidence available to provide standard care that is in the best interest of their patients.
Study NCT03689049 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care
Description: Physicians and their teams enrolled in this arm will follow the best scientific evidence available to provide standard care that is in the best interest of their patients.
Study NCT02236325 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DBT Brief Suicide Intervention
Description: Participants assigned to the DBT Brief Suicide Intervention are presented with a selection of coping strategies selected from the Dialectical Behavior Therapy (DBT) skills training curriculum. The strategies are 1) mindfulness, 2) mindfulness of current emotions, 3) opposite-to-emotion action, 4) distraction, and 5) changing your body chemistry.
Study NCT02236325 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Training
Description: Participants assigned to the Relaxation Training condition receive instruction in a sensory awareness practice and are guided through the practice by the therapist.
Study NCT02964273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Description: Tolvaptan spray-dried, immediate release tablets
Study NCT02964273 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tolvaptan Matching-placebo
Description: Tolvaptan matching-placebo tablets
Study NCT03440463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-checkup to go
Description: The e-checkup to go substance program is designed to motivate individuals to reduce their consumption using personalized information about their own use and risk factors. The program is a combination of several components including alcohol education, personalized feedback, attitude-focused strategies, and skills training. It is self-guided and requires no face-to-face time with an administrator. It provides tailored feedback regarding quantity and frequency of alcohol use, normative comparisons, physical health information, amount and percent of income spent on alcohol, negative consequences feedback, explanation and advice for how to reach their goals, and resources.
Study NCT03440463 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: e-checkup to go
Description: The e-checkup to go substance program is designed to motivate individuals to reduce their consumption using personalized information about their own use and risk factors. The program is a combination of several components including alcohol education, personalized feedback, attitude-focused strategies, and skills training. It is self-guided and requires no face-to-face time with an administrator. It provides tailored feedback regarding quantity and frequency of alcohol use, normative comparisons, physical health information, amount and percent of income spent on alcohol, negative consequences feedback, explanation and advice for how to reach their goals, and resources.
Study NCT03440463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Norms-only booster
Description: Booster emails will contain normative feedback indicating average consumption for students at the same institution by sex, their perceptions of student drinkers at the same institution, their own reported consumption, and how they compare.
Study NCT03440463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Norms-plus-Strategies booster
Description: Booster emails will contain normative feedback indicating average consumption for students at the same institution by sex, their perceptions of student drinkers at the same institution, their own reported consumption, and how they compare. These booster emails will also contain reminders of strategies they can use to protect themselves from alcohol-related harm, both ones they've reported using in the past and others they might consider using in the future.
Study NCT04359524 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 (1200 IU/30µg)
Study NCT04359524 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oil capsule
Study NCT03372720 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser Therapy
Description: Undergo fractional CO2 laser therapy
Study NCT03372720 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03372720 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03372720 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Intervention
Description: Undergo sham laser therapy
Study NCT02345408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CCX872-B
Description: Tablets (oral administration)
Study NCT01132950 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Two personalized sessions of motivational interviewing. The first one is given while the participant is in jail and the second one is given at 3 months post release.
Study NCT01132950 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Didactic Educational Counseling
Description: Participant will watch an educational video while in jail and a second educational video at 3 months post release.
Study NCT00205803 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 7-Valent Pneumococcal Conjugate Vaccine (7vPnC)
Study NCT00928161 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexlansoprazole
Description: Dissolving tablet taken by mouth (60 mg tablet), once a day. Take dose first thing in morning on empty stomach, then nothing but water for 30-45 minutes afterwards.
Study NCT05854810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: fertilized embryo Insertion
Description: insertion of single fertilized embryo through IVF
Study NCT00570466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Games
Description: Two interactive, computer-based video games (9 sessions each) played in sequence to increase fruit,vegetable,water intake + physical activity + decrease TV viewing.
Study NCT05854810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: fertilized embryo Insertion
Description: insertion of double fertilized embryo through IVF
Study NCT04359511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: prednisone 0.7 mg/kg/d (PO)
Study NCT02319460 — intervention group
Intervention type: BIOLOGICAL
Intervention: Kcentra®
Description: Kcentra®, Prothrombin Complex Concentrate (Human), is a blood coagulation factor replacement product that contains coagulation Factors II, VII, IX and X, and antithrombotic Proteins C and S as a lyophilized concentrate.
Study NCT02319460 — intervention group
Intervention type: BIOLOGICAL
Intervention: Plasma
Study NCT00570466 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Web and DVD knowledge
Description: Web and DVD based knowledge games
Study NCT02162225 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: beet juice (Unbeetable)
Description: Volunteers will drink a single 8 ounce bottle of beet juice (Unbeetable) per day for 28 days.~On days 1,14, and 28, the juice will be drunk just prior to having blood drawn. Blood will also be drawn 1.5 hours after drinking the juice on days 1,14, and 28.
Study NCT03582592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fluid Distribution Timetable
Description: It is a scheduled distribution of pre-determined amounts of fluid intake on a daily basis depicted via a 5x6 table. The timetable includes three major columns. The first column has six timepoints of a day with a four-hour interval. The second column, which was further divided into four sub-columns, reflects the percentage of fluid allotment for food, activities, medication, and thirst encounters. The percentage of fluid allocation was computed based on the patient's prescribed fluid restriction, usual time of food intakes in a day, usual level of activity, time of medication intake, and common time they encounter thirst in a day. Lastly, the third column indicates the converted percentages of fluid allotment in milliliters.
Study NCT05249842 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spirometric evaluation
Description: Evaluation of: forced vital capacity (FVC),, FEV1', FEV 1/FVC, FEF 25-75
Study NCT05249842 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Physical component summary
Description: Evaluation of the physical component summary of SF-36 quality of life
Study NCT05249842 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 6MWT
Description: 6 minute walk test
Study NCT04017793 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness Based Stress Reduction
Description: Structured 8-week training program teaching about increased mindfulness strategies and gentle stretching.
Study NCT04017793 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Group
Description: 8-weekly group discussion meetings reviewing relaxation techniques and other stress reduction strategies with an emphasis on social support.
Study NCT02379260 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Interview with a sociologist
Study NCT00698113 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Massage
Description: Children will receive a 10-15 minute massage seated (clothed), or in bed (clothed or unclothed) each day using the following protocol: stroking, effleurage, petrissage, muscle squeezing, effleurage, stroking. Massaged areas can include the back, arms and legs.~Parents will receive a one hour educational session with a Massage Therapist, a DVD, and written materials that all illustrate the required protocol.
Study NCT00698113 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Journaling
Description: Children will complete weekly journals about their feelings. These journals will either be drawn or written based on the preference of the child. Parents will complete a weekly journal outlining the number of massages given to their child, barriers that prevented massage, and their experience of giving the massage.
Study NCT00698113 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Journaling
Description: Children will complete weekly journals about their feelings. These journals will either be drawn or written based on the preference of the child. Parents will complete a weekly journal outlining the number of massages given to their child, barriers that prevented massage, and their experience of giving the massage.
Study NCT02035046 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Samplings of blood
Study NCT02035046 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Sampling of urine
Study NCT02035046 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Measure of the blood pressure
Study NCT02035046 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: glycemia test
Study NCT02492412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HE 10
Study NCT02492412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Restasis
Study NCT00731614 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy and Mirror Retraining
Description: Cognitive Behavioral Pain Management treatment administered in 8 weeks of individual treatment, combined with training in use of a mirror device to reduce phantom limb pain.
Study NCT00731614 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supportive therapy
Description: Non-directive, emotion focused psychotherapy to facilitate coping with pain, delivered in weekly individual sessions.
Study NCT00731614 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mirror retraining
Description: Use of a mirror to produce an illusion of the missing limb. By attending to the reflected limb while moving the existing limb, the patient provides visual feedback that helps correct changes in the neural organization of the somatosensory cortex resulting from the amputation and contributing to the phantom limb pain
Study NCT00943917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ITCA 650
Description: ITCA 650 (continuous delivery of exenatide in DUROS)
Study NCT00943917 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exenatide Injection
Description: twice daily (BID) injections of exenatide commercially available Byetta: 5 mcg/dose first 12 weeks then 10 mcg/dose for 8 weeks
Study NCT00943917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ex Inj/ITCA 650
Description: twice-daily (BID) exenatide injection: 5 mcg/dose for 4 weeks then 10 mcg/dose for 8 weeks, followed by ITCA 650
Study NCT03095872 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CO2-laser
Description: Patients with photo-damaged skin are treated with the CO2 laser to remove damaged skin layers.
Study NCT03095872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaseline
Description: After the laser treatment, the wound area will be divided into two parts with a sterile skin marker. One area will be treated with Vaseline, and be marked V. Thus, it is ensured that the care product will be applied correctly to the defined area. Postoperatively, this area of the wound will be treated with Vaseline. In the next seven days the patient will repeat the treatment every day at home.
Study NCT03095872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bepanthen
Description: After the laser treatment, the wound area will be divided into two parts with a sterile skin marker. One area will be treated with Bepanthen® Wund- und Heilsalbe, and be marked B. Thus, it is ensured that the care product will be applied correctly to the defined area. Postoperatively, this area of the wound will be treated with Bepanthen® Wund- und Heilsalbe. In the next seven days the patient will repeat the treatment every day at home.
Study NCT03631407 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vicriviroc
Description: Vicriviroc tablets administered orally, QD at dose level 1 or 2.
Study NCT03631407 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab administered by IV infusion at 200 mg every 3 weeks (Q3W), given on cycle day 1.
Study NCT03447457 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: High-flow oxygen
Description: HFNC is continuously applied via large-bore nasal prongs with a gas flow rate of 50 L/min and a FiO2 adjusted to maintain a pulse oxymetry at least 92%
Study NCT03447457 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Standard oxygen
Description: nasal cannula, face mask or non-rebreathing reservoir mask
Study NCT02357472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dehydroepiandrosterone
Description: high dose group treatment represent for 50mg t.i.d and standard dose group represents for normal treatment with 25mg t.i.d. Each patients in these two group will take one capsule each time and three times a day for three months before entering into IVF cycles.
Study NCT01160354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plerixafor
Description: Starting at 240 mcg/kg daily subcutaneous (SQ) injection on Days 1-5, 4-6 hours before a 1 hour (+/- 30 minutes) IV administration of Clofarabine
Study NCT01160354 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofarabine
Description: Fixed dose of 30 mg/m2/day during Induction cycle (20 mg/m2/day in consolidation cycles).
Study NCT02426229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran etexilate
Description: dabigatran etexilate 75mg orally twice a day for 6 months
Study NCT03247842 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: suprascapular nerve block
Description: Sixty patients with shoulder dystocia after breast surgery will receive stellate ganglion neurolysis with supra-scapular nerve radiofrequency,
Study NCT04547764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triple antibiotic paste (TAP)
Description: root canal treatment of pulpally involved teeth.
Study NCT04547764 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitapex (calcium hydroxide/iodoform paste)
Description: root canal treatment of pulpally involved teeth.
Study NCT02463214 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Engineered Room
Description: Touchless devices:~Hand sanitizers, faucets, paper towel dispensers, call devices, Ultraviolet C Aseptix™ Disinfection devices above bathroom doors~Copper products:~Room and bathroom entrance door hardware, over bed table and bed side table surfaces, chair metal arms, wardrobe handles and knobs, weigh scale, sinks, grab bars, light switch panels, toilet flush handles, faucets and handles, patient bed rails.~Titanium dioxide paint:~Room walls, head walls, light switches, bathroom wall shelves, toilet tank and bowl, head wall unit fixed equipment, television remote and Bed Control remote
Study NCT04544319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zemiglo 50mg and Forxiga 10mg
Description: Each component of Gemigliptin 50mg QD and Dapagliflozin 10mg QD
Study NCT04544319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fixed-dose Combinations of Gemigliptin/Dapagliflozin 50/10 mg
Description: Fixed-dose Combinations of Gemigliptin/Dapagliflozin 50/10 mg QD